Strengthens
the inspiratory muscles
·
As
you inhale against the load, the inspiratory muscles are made
to work harder; this training stimulus induces improvements in
the force-generating capacity and metabolic efficiency of the
inspiratory muscles (Sharpe
et al., unpublished observations)
Breathing
improved in 3 weeks
·
Training
is accomplished with as little as 5 minutes training per day,
and benefits are perceived by patients within 3 weeks of
starting the training (McConnell
et al., 1998)
Relie
ves
the symptoms of Asthma
·
In
randomised, controlled trials, on mild / moderate asthmatics,
POWERbreathe increased inspiratory muscle strength by a mean
of 11% in just 3 weeks (McConnell
et al., 1998)
·
Inspiratory
muscle training has been shown to relieve the symptoms of
asthma by improving lung function, resulting in reduction of
medication and a fall in hospitalisations (Weiner
et al., 1992)
Relieves
the symptoms of Dyspnoea and other respiratory disorders
·
Dyspnoea
is a common feature of many disorders. Its source may be
respiratory, cardiovascular, neuromuscular or even
psychological. Inspiratory muscle weakness has been identified
as a contributory factor in the perception of dyspnoea (Killian,
1998)
·
Training
of the inspiratory muscles has been demonstrated to increase
their strength, resistance to fatigue and, most importantly,
to reduce exertional dyspnoea. (Lisboa,
1994; Copestake & McConnell, 1995; Lisboa, 1997; McConnell
et al., 1998)
·
Reduction
in exertional dyspsnoea has been demonstrated in healthy
elderly people (Copestake&
McConnell, 1995), asthmatics (McConnell
et al., 1998) and patients with COPD (Lisboa
et al., 1994, 1997)
Proven to enhance endurance in patients with COPD
(Chronic Obstructive Lung Disease)
·
In
randomised, controlled trials, POWERbreathe has been shown to
generate improvements in inspiratory muscle strength of 55%
and endurance of 86% in patients with COPD
(Newall et al., 1998)
Inspiratory
muscle training has improved inspiratory muscle function in
the following conditions:
·
Spinal
cord injury (Huldtgren
et al., 1980, Gross et al., 1980)
·
Cystic fibrosis
(Sawyer et al., 1993)
·
Chronic
heart failure (Cahalin
et al., 1997, Mancini et al., 1995)
·
Neuromuscular
diseases including MS (Foglio
et al., 1994), Duchenne muscular dystrophy (Wanke
et al., 1994)
·
Heart-lung
transplant patients (Ambrosino
et al., 1996)
Maintenance
of lung function during Corticosteroid use
·
Corticosteroids
are used to treat a large number of disease conditions, but
significant reductions in inspiratory muscle strength have
been documented after an acute bout of oral corticosteroid
treatment. Research has shown that a concomitant period of
inspiratory muscle training can eliminate the fall in
inspiratory
muscle strength, therefore maintaining lung function
during corticosteroid use (Weiner
et al., 1995)
|